<code id='06043C5EF6'></code><style id='06043C5EF6'></style>
    • <acronym id='06043C5EF6'></acronym>
      <center id='06043C5EF6'><center id='06043C5EF6'><tfoot id='06043C5EF6'></tfoot></center><abbr id='06043C5EF6'><dir id='06043C5EF6'><tfoot id='06043C5EF6'></tfoot><noframes id='06043C5EF6'>

    • <optgroup id='06043C5EF6'><strike id='06043C5EF6'><sup id='06043C5EF6'></sup></strike><code id='06043C5EF6'></code></optgroup>
        1. <b id='06043C5EF6'><label id='06043C5EF6'><select id='06043C5EF6'><dt id='06043C5EF6'><span id='06043C5EF6'></span></dt></select></label></b><u id='06043C5EF6'></u>
          <i id='06043C5EF6'><strike id='06043C5EF6'><tt id='06043C5EF6'><pre id='06043C5EF6'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:87344
          illustration of osteoarthritis in the knee joint -- chronic disease health coverage from STAT
          Adobe

          A kind of protein implicated in Alzheimer’s disease might also contribute to the breakdown of cartilage that’s characteristic of osteoarthritis. 

          In a new study, published in Science Translational Medicine on Wednesday, researchers analyzed tissue samples and joint fluid from 12 people, both those with osteoarthritis and healthy controls. They found those with osteoarthritis in their knee had a fourfold increase in apolipoprotein E, or APOE.

          advertisement

          Despite being common, the how of osteoarthritis has mostly eluded scientists. The new research offers a novel idea with an unlikely protein.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Bispecific antibodies are next new thing in cancer immunotherapy
          Bispecific antibodies are next new thing in cancer immunotherapy

          IllustrationofaBiTE,Amgen'sbispecificantibodiesAmgenIncancerimmunotherapythesedays,technologyisadvan

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Digital health funding stays low as a new reality sets in

          AdobeYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Sign